ArchPoint Investors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $395K | Hold |
115,055
| – | – | 0.12% | 58 |
|
|
2025
Q1 | $257K | Hold |
115,055
| – | – | 0.08% | 62 |
|
|
2024
Q4 | $337K | Hold |
115,055
| – | – | 0.11% | 57 |
|
|
2024
Q3 | $299K | Hold |
115,055
| – | – | 0.1% | 61 |
|
|
2024
Q2 | $341K | Hold |
115,055
| – | – | 0.13% | 60 |
|
|
2024
Q1 | $521K | Hold |
115,055
| – | – | 0.22% | 52 |
|
|
2023
Q4 | $657K | Hold |
115,055
| – | – | 0.27% | 35 |
|
|
2023
Q3 | $529K | Hold |
115,055
| – | – | 0.2% | 42 |
|
|
2023
Q2 | $743K | Hold |
115,055
| – | – | 0.29% | 39 |
|
|
2023
Q1 | $868K | Hold |
115,055
| – | – | 0.38% | 34 |
|
|
2022
Q4 | $1.17M | Sell |
115,055
-502,158
| -81% | -$5.09M | 0.55% | 33 |
|
|
2022
Q3 | $6.1M | Sell |
617,213
-13,113
| -2% | -$130K | 2.49% | 12 |
|
|
2022
Q2 | $6.71M | Buy |
630,326
+169,037
| +37% | +$1.8M | 2.66% | 11 |
|
|
2022
Q1 | $4.5M | Hold |
461,289
| – | – | 1.55% | 18 |
|
|
2021
Q4 | $6.6M | Hold |
461,289
| – | – | 1.96% | 15 |
|
|
2021
Q3 | $9.24M | Buy |
+461,289
| New | +$9.24M | 2.77% | 7 |
|